CLINICAL_TRIALS
trial_result
· 2013-09-04
Clinical Trial Update: Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept [Phase 3]
Summary
A Phase 3 trial of pioglitazone in Friedreich's ataxia has been completed. The study provides a proof-of-concept for this approach.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Friedreich's Ataxia | Phase 3 | Status: COMPLETED